Zessly
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zessly, covering 2025-06-24 to 2025-06-24. Get the full timeline:
Most recent: EMA Authorised: Zessly (infliximab) — Sandoz GmbH
1 regulatory and trial event tracked for Zessly, covering 2025-06-24 to 2025-06-24. Get the full timeline:
Most recent: EMA Authorised: Zessly (infliximab) — Sandoz GmbH